EUVIMEDEUVIMED entdecken
Crossref

UBE2S Promotes KIRC Progression by Regulating CDC20 Expression and Suppressing FDX1‐Mediated Cuproptosis, While Promoting M2 Macrophage Polarization

Junru Chen, Yu Gao, Yuelong Feng, Hao Yang, Gang Jia, Jiao Wei, Lingxia Zhang, Zhizhong Zhang iD

Molecular Carcinogenesis · 2026

DOI: 10.1002/mc.70171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2026. Verfasst von Junru Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Urology Department, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China. Hauptthemen laut MEDLINE: Ubiquitin-Conjugating Enzymes, Cuproptosis, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Ningxia Natural Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to investigate the biological function, molecular mechanisms, and impact on the tumor microenvironment of the ubiquitin‐conjugating enzyme E2S (UBE2S) in the progression of kidney renal clear cell carcinoma (KIRC). Based on the TCGA and GEPIA databases, the relationship between UBE2S expression and patient prognosis was analyzed. Overexpression and knockdown models of UBE2S were established in Caki‐1 and 786‐O cell lines. Cell proliferation, apoptosis, and migration capabilities were assessed using CCK‐8 assay, colony formation assay, flow cytometry, wound healing assay, and Transwell assay. Protein‐protein interactions and expression regulatory mechanisms were validated by co‐immunoprecipitation and Western blot. The proteasome inhibitor MG132 and ubiquitination assays were employed to investigate protein degradation mechanisms. Macrophage polarization was analyzed using a cell co‐culture system, immunofluorescence staining, and Western blot. UBE2S is highly expressed in KIRC tissues and is associated with poor patient prognosis. Functional experiments demonstrate that UBE2S promotes KIRC cell proliferation and migration while inhibiting apoptosis. Mechanistically, UBE2S directly binds to and positively regulates CDC20 protein expression, and its oncogenic functions depend on CDC20. Furthermore, knockdown of UBE2S induces cuproptosis by activating FDX1 protein, thereby enhancing cellular sensitivity to cuproptosis inducers. UBE2S promotes FDX1 protein degradation via the ubiquitin‐proteasome pathway. Additionally, tumor cells with high UBE2S expression promote macrophage polarization toward the M2 phenotype. UBE2S drives KIRC progression by regulating CDC20 expression and suppressing FDX1‐mediated cuproptosis, thereby promoting tumor‐associated macrophage polarization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Conjugating EnzymesCuproptosisCarcinoma, Renal CellKidney NeoplasmsCdc20 ProteinsMacrophagesHumansGene Expression Regulation, NeoplasticCell ProliferationCell MovementApoptosisAnimalsDisease ProgressionCell Line, TumorPrognosisMiceMacrophage Activation

Stichwörter der Autor:innen

CDC20M2 macrophage polarizationUBE2Scuproptosiskidney renal clear cell carcinomaubiquitination

Substanzen

Ubiquitin-Conjugating EnzymesCdc20 ProteinsUbe2S protein, humanCDC20 protein, human

Autor:innen und Institutionen

  • Urology Department, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.
  • Urology Department, General Hospital of Ningxia Medical University, Yinchuan, China.
  • Anesthesia Surgery Department, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.

ORCID-Profile: Zhizhong Zhang

Förderung

  • Ningxia Natural Science Foundation Project

Zitieren

APA

Chen, J., Gao, Y., Feng, Y., Yang, H., Jia, G., Wei, J., Zhang, L., & Zhang, Z. (2026). UBE2S Promotes KIRC Progression by Regulating CDC20 Expression and Suppressing FDX1‐Mediated Cuproptosis, While Promoting M2 Macrophage Polarization. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70171

Vancouver

Chen J, Gao Y, Feng Y, Yang H, Jia G, Wei J, et al. UBE2S Promotes KIRC Progression by Regulating CDC20 Expression and Suppressing FDX1‐Mediated Cuproptosis, While Promoting M2 Macrophage Polarization. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70171

BibTeX
@article{Chen2026,
  author = {Chen, Junru and Gao, Yu and Feng, Yuelong and Yang, Hao and Jia, Gang and Wei, Jiao and Zhang, Lingxia and Zhang, Zhizhong},
  title = {UBE2S Promotes KIRC Progression by Regulating CDC20 Expression and Suppressing FDX1‐Mediated Cuproptosis, While Promoting M2 Macrophage Polarization},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70171}
}
Kostenlos starten →